Andrighetti-Fröhner CR, Antonio RV, Creczynski-Pasa TB, Barardi CRM, Simões CMO (2003). Cytotoxicity and potential antiviral evaluation of violacein produced by Chromobacterium violaceum. Mem. Inst. Oswaldo Cruz, Rio de Janeiro 98:843-848.

Ang YM (2004). A very rare and rapidly fatal case of Chromobacterium Violaceum septicemia. Med. J. Malays. 59:535-537.
Pubmed

Antônio RV, Creczynski-Pasa TB (2004). Genetic analysis of violacein biosynthesis by Chromobacterium violaceum. Genet. Mol. Res. 3:85-91.
Pubmed

Anthony M, Ashiq M, Salim S, Sajudeen PA, Nair IC, Jayachandran K (2013). Inhibition of violacein synthesis in Chromobacterium violaceum DSTS-1 mutant. Int. J. Adv. Biotechnol. Res. 4:1014-1020.

Antunes AA, Silva MLRB, Silva CAA, Campos-Takaki GM (2006). Characterization of Chromobacterium violaceum isolated from Paca River, Pernambuco, Brazil. Revista de Biologia e Ciências da Terra 1:48-55.

Arosio M, Raglio A, Ruggeri M, Ortega PS, Morali L, De Angelis C, Goglio A (2011). Chromobacterium violaceum lymphadenitis successfully treated in a Northern Italian hospital. New Microbiol. 34:429-432.
Pubmed

August PR, Grossman TH, Minor C, Draper MP, MacNeil IA, Pemberton JM, Call KM, Holt D, Osburne MS (2000). Sequence analysis and functional characterization of the violacein biosynthetic pathway from Chromobacterium violaceum. J. Mol. Microbiol. Biotechnol. 2:513-519.
Pubmed

Ballantine JA, Beer RJ, Crutchley DJ, Dodd GM, Palmer DR (1958). The synthesis of violacein and related compounds. Proc. Chem. Soc. 1:232-233.

Bauer AW, Kirby WMM, Sherris JC, Turck M (1966). Antibiotic susceptibility testing by a standardized single disk method. Am. J. Clin. Pathol. 45:493-496.
Pubmed

Becker MH, Brucker RM, Schwantes CR, Harris RN, Minbiole KPC (2009). The bacterially produced metabolite violacein is associated with survival of amphibians infected with a lethal fungus. Appl. Environ. Microbiol. 75: 6635-6638.
Crossref

Bergonzini C (1880). Sopra un nuovo bacterio colorato. Annuario dells Societa dei naturalisti in Modena, ser. 2 Anno 14, Parte Scientifica 149-158; Parte officiale 37.

Bhubalan K, Kam YC, Yong KH, Sudesh K (2010). Cloning and expression of the PHA synthase gene from a locally isolated Chromobacterium sp. USM2. Malays. J. Microbiol. 6:81-90.

Brazilian National Genome Project Consortium (2003). The complete genome sequence of Chromobacterium violaceum reveals remarkable and exploitable bacterial adaptability. Proc. Natl. Acad. Sci. USA 100:11660-11665.
Crossref

Brito CF, Carvalho CB, Santos F, Gazzinelli RT, Oliveira SC, Azevedo V, Teixeira SM (2004). Chromobacterium violaceum genome: molecular mechanisms associated with pathogenicity. Genet. Mol. Res. 3:148-161.
Pubmed

Campbell JI, Lan NPH, Qui PT, Dung LT, Farrar JJ, Baker S (2013). A successful antimicrobial regime for Chromobacterium violaceum induced bacteremia. BMC Infect. Dis.13:4.
Crossref

Cappuccino J, Sherman N (2013). Microbiology - a laboratory manual 10/E. Pearson, USA.

Cardona-Cardona V, Arroyo D, Scellekens J, Rios-Velazquez C (2010). Characterization of blue pigmented bacteria isolated from Puerto Rico. In: Méndez-Vilas A (ed). Current Research, Technology and Education Topics in Applied Microbiology and Microbial Biotechnology. Formatex 117-123.

Chang CY, Lee YT, Liu KS, Wang YL, Tsao SM (2007). Chromobacterium violaceum infection in Taiwan: a case report and literature review. J. Microbiol. Immunol. Infect. 40:272-275.
Pubmed

Cheong BMK (2010). A fatal case of pulmonary Chromobacterium violaceum infection in an adult. Med. J. Malays. 65:148-149.
Pubmed

Chernin LS, Winson MK, Thompson JM, Haran S, Bycroft BW, Chet I, Williaams P, Stewart GSAB (1998). Chitinolytic activity in Chromobacterium violaceum: substrate analysis and regulation by quorum sensing. J. Bacteriol. 180:4435-4441.
Pubmed

Chess B (2009). Laboratory Applications in Microbiology - a case study approach. McGraw Hill, New York.

Choo JH, Rukayadi Y, Hwang JK (2006). Inhibition of bacterial quorum sensing by vanilla extract. Soc. Appl. Microbiol. Lett. Appl. Microbiol. 42:637-641

Corpe WA (1964). Factors influencing growth and polysaccharide formation by strains of Chromobacterium violaceum. J. Bacteriol. 88:1433-1441.
Pubmed

de Carvalho DD, Costa FTM, Durán N, Haun M (2006). Cytotoxic activity of violacein in human colon cancer cells. Toxicol. In Vitro 20:1514-1521.
Crossref

Durán N, Justo GZ, Ferreira CV, Melo PS, Cordi L, Martins D (2007). Violacein: properties and biological activities. Biotechnol. Appl. Biochem. 48:127-133.
Crossref

Durán N, Menck CF (2001). Chromobacterium violaceum: a review of pharmacological and industrial perspectives. Crit. Rev. Microbiol. 27:201-222.
Crossref

Durán N, Erazo S, Campos V (1983). Bacterial chemistry-II: antimicrobial photoproduct from pigment of Chromobacterium violaceum. Anais da Academia Brasileira de Ciências 55:231-234.

Faramarzi MA, Stagars M, Pensini E, Krebs W, Brandl H (2004). Metal solubilization from metal-containing solid materials by cyanogenic Chromobacterium violaceum. J. Biotechnol. 113: 321-326.
Crossref

Grimes DJ, Woese CR, MacDonell MT, Colwell RR (1997). Systematic Study of the Genus Vogesella gen. nov. and its type species, Vogesella indigofera comb. nov. Int. J. Syst. Bacteriol. 47:19-27.
Crossref

Groves MG, Strauss JM, Abbas J, Davis CE (1969). Natural infections of gibbons with a bacterium producing violet pigment (Chromobacterium violaceum). J. Infect. Dis. 120: 605-610.
Crossref

Holmes DS, Quigley M (1981). A rapid boiling method for the preparation of bacterial plasmids. Anal. Biochem. 114:193-197.
Crossref

Humble MW, King A, Philips I (1977). API ZYM: a simple rapid system for the detection of bacterial enzymes. J. Clin. Pathol. 30:275-277.
Crossref

Hungria M, Nicolás MF, Guimarães CT, Jardim SN, Gomes EP, Vasconcelos ATR (2004). Tolerance to stress and environmental adaptability of Chromobacterium violaceum. Genet. Mol. Res. 3:102-116.
Pubmed

Jitmuang A (2008). Human Chromobacterium violaceum infection in Southeast Asia: case reports and literature review. Southeast Asian J. Trop. Med. Public Health 39:452-460.
Pubmed

Kaufman SC, Ceraso D, Schugurensky A (1986). First case report from Argentina of fatal septicaemia caused by Chromobacterium violaceum. J. Clin. Microbiol. 23:956-958.
Pubmed

Knowles CJ (1976). Microorganisms and cyanide. Bacteriol. Rev. 46:652-680.

Kumar MR (2012) Chromobacterium violaceum: A rare bacterium isolated from a wound over a scalp. Int. J. Appl. Basic. Med. Res. 2:70-72.
Crossref

Lammert JM (2007) Techniques for Microbiology: a student handbook. Pearson Education Inc.

Lee J, Kim JS, Nahm CH, Choi JW, Kim J, Pai SH, Moon KH, Lee K, Chong Y (1999). Two cases of Chromobacterium violaceum infection after injury in a subtropical region. Am. Soc. Microbiol. 37:2068-2070.

Leon LL, Miranda CC, De Souza AO, Durán N (2001). Antileishmanial activity of the violacein extracted from Chromobacterium violaceum. J. Antimicrob. Chemother. 48:449-450.
Crossref

Liasi SA, Azmi TI, Hassan MD, Shuhaimi M, Rosfarizan M, Ariff AB (2009). Antimicrobial activity and antibiotic sensitivity of three isolates of lactic acid bacteria from fermented fish product, Budu. Malays. J. Microbiol. 5:33-37.

Lichstein HC, Van de Sand VF (1945). Violacein, an antibiotic pigment produced by Chromobacterium violaceum. J. Infect. Dis. 76:47-51.
Crossref

Lopes SCP, Blanco YC, Justo GZ, Nogueira PA, Rodrigues FLS, Goelnitz U, Gerhard Wunderlich G, Facchini G, Brocchi M, Durán N, Costa FTM (2009). Violacein extracted from Chromobacterium violaceum inhibits Plasmodium growth in vitro and in vivo. Antimicrobiol. Agents Chemother. 53: 2149-2152.
Crossref

Malghani S, Chatterjee N, Yu HX, Luo Z (2009) Isolation and identification of profenofos degrading bacteria. Braz. J. Microbiol. 40:893-900.
Crossref

Martin JP, Richard SJ (1963). Decomposition and binding action of a polysaccharide from Chromobacteriumi violaceum in soil. J. Bacteriol. 85:1288-1294.
Pubmed

Matz C, Deines P, Boenigk J, Arndt H, Eberl L, Kjelleberg S, Jürgens K (2004). Impact of violacein-producing bacteria on survival and feeding of bacterivorous nanoflagellates. Appl. Environ. Microbiol. 70: 1593-1599.
Crossref

McClean KH, Winson MK, Fish L, Taylor A, Chhabra SR, Camara M, Daykin M, Lamb JH et al. (1997). Quorum sensing and Chromobacterium violaceum: exploitation of violacein production and inhibition for the detection of N-acylhomoserine lactones. Microbiology 143:3703-3711.
Crossref

Miller MB, Bassler BL (2001) Quorum sensing in bacteria. Ann. Rev. Microbiol. 55:165-199.
Crossref

Moore CC, Lane JE, Stephens JL (2001). Successful treatment of an infant with Chromobacterium violaceum sepsis. Clin. Infect. Dis. 32:107-110.
Crossref

Rettori D, Durán N (1998). Production, extraction and purification of violacein: an antibiotic produced by Chromobacterium violaceum. World J. Microbiol. Biotechnol. 14:685-688.
Crossref

Rodgers PB, Knowles CJ (1978). Cyanide production and degradation during growth of Chromobacterium violaceum. J. Gen. Microbiol. 108:261-267.
Crossref

Saigin DD, Dolkadir J, Tan PT (1994). Chromobacterium violaceum infection in Malaysia. Asian Med. J. 37:47-51.

Saleem S, Kamili AN, Kakru DK, Bandh SA, Ganai BA (2011). Isolation, identification and seasonal distribution of bacteria in Dal Lake, Kashmir. Int. J. Environ. Sci. 2:185-193.

Shamshuddin J, Mokhtar N, Paramananthan S (1986). Morphology, mineralogy and chemistry of an ex-mining land in Ipoh, Perak. Pertanika 9:89-97.

Sneath PHA, Whelan JPF, Singh RB, Edwards D (1953). Fatal infection by Chromobacterium violaceum. Lancet 1953:276-277.
Crossref

Strong FM (1944) Isolation of violacein. Science 100:287.
Crossref

Sureisen M, Choon SK, Tai CC (2008). Recurrent Chromobacterium violaceum infection in a patient with chronic granulomatous disease. Med. J. Malays. 63:346-347.
Pubmed

Wooley PG (1905). Bacillus violaceum manilae (a pathogenic organism). Bull. Johns Hopkins Hosp. 16:89-93.

Yang CH, Li YH (2011). Chromobacterium violaceum infection: A clinical review of an important but neglected infection. J. Chin. Med. Assoc. 74:435-441.
Crossref